|
|
||||||||
Ann Thorac Surg 1987;43:397-402
© 1987 The Society of Thoracic Surgeons
Department of Surgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA
Accepted for publication June 25, 1986.
* Address reprint requests to Dr. Daggett, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114
It has been clearly shown, both in a laboratory model and in humans, that oxygenation of crystalloid cardioplegic solutions markedly enhances myocardial preservation. The addition of a small volume of red cells to a crystalloid perfusate improves capillary perfusion. Based on these results, we have changed our cardioplegic solution from cold crystalloid to cold oxygenated dilute blood. In the present study we retrospectively evaluate the results of 400 operative procedures to determine whether the addition of oxygenation and a small volume of blood to the cardioplegic solution enhances myocardial protection in the clinical setting. Two hundred consecutive patients who underwent operation with cardioplegic arrest using a cold crystalloid cardioplegic solution (group 1) were compared with a subsequent 200 patients who underwent operation with cold oxygenated dilute blood cardioplegia (group 2). Patients in group 2, who received cold oxygenated dilute blood cardioplegia, had a significantly reduced need for postoperative intraaortic balloon pump counterpulsation and for atrioventricular pacing. Also, patients in group 2 had a lower incidence of perioperative myocardial infarction and had improved early outcome. None of the 200 patients in group 2 had electrocardiographic evidence of perioperative infarction. We conclude that cold oxygenated dilute blood cardioplegia provides better preservation than does a nonoxygenated crystalloid solution during elective ischemic arrest, because a cold crystalloid solution is able to deliver oxygen and the red cells are able to enhance capillary perfusion.
This article has been cited by other articles:
![]() |
B. Braathen and T. Tonnessen Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 874 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture Card. Surg. Adult, January 1, 2008; 3(2008): 753 - 784. [Full Text] |
||||
![]() |
C.-H. Yeh, Y.-C. Wang, Y.-C. Wu, J.-J. Chu, and P. J. Lin Continuous Tepid Blood Cardioplegia Can Preserve Coronary Endothelium and Ameliorate the Occurrence of Cardiomyocyte Apoptosis Chest, May 1, 2003; 123(5): 1647 - 1654. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Chaudhry, P. R. Belcher, S. P. Day, E. W. Muriithi, and D. J. Wheatley Erythrocyte-containing versus crystalloid cardioplegia in the rat: effects on myocardial capillaries Ann. Thorac. Surg., March 1, 2003; 75(3): 890 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr. Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture Card. Surg. Adult, January 1, 2003; 2(2003): 681 - 714. [Full Text] |
||||
![]() |
W. G. Hendren, D. D. O'Keefe, G. A. Geffin, A. G. Denenberg, T. R. Love, and W. M. Daggett Maximal oxygenation of dilute blood Cardioplegic solution Ann. Thorac. Surg., November 1, 1994; 58(5): 1558 - 1559. [Abstract] [PDF] |
||||
![]() |
T. L. Demmy, S. P. Haggerty, T. M. Boley, and J. J. Curtis Lack of cardioplegia uniformity in clinical myocardial preservation Ann. Thorac. Surg., March 1, 1994; 57(3): 648 - 651. [Abstract] [PDF] |
||||
![]() |
J. Golembiewski and N. Bourtsos Cardioplegia Solution Journal of Pharmacy Practice, August 1, 1993; 6(4): 182 - 189. [Abstract] [PDF] |
||||
![]() |
Y. A. G. Louagie, E. Collard, M. Gonzalez, A. Gruslin, J. Jamart, V. Delire, A. Mayne, M. Buche, and J.-C. Schoevaerdts Initial experience with low-potassium cold blood cardioplegia: A clinical comparative study Ann. Thorac. Surg., April 1, 1992; 53(4): 628 - 634. [Abstract] [PDF] |
||||
![]() |
J. Vinten-Johansen, J. S. Julian, H. Yokoyama, W. E. Johnston, T. D. Smith, D. S. McGee, and A. R. Cordell Efficacy of myocardial protection with hypothermic blood cardioplegia depends on oxygen Ann. Thorac. Surg., October 1, 1991; 52(4): 939 - 948. [Abstract] [PDF] |
||||
![]() |
H. Gohra, F. Mori, and K. Esato The effect of fluorocarbon emulsion on 24-hour canine heart preservation by coronary perfusion Ann. Thorac. Surg., July 1, 1989; 48(1): 96 - 103. [Abstract] [PDF] |
||||
![]() |
T. R. Reynolds, G. A. Geffin, J. S. Titus, D. D. O'Keefe, and W. M. Daggett Myocardial preservation related to magnesium content of hyperkalemic cardioplegic solutions at 8 {degrees}C Ann. Thorac. Surg., June 1, 1989; 47(6): 907 - 913. [Abstract] [PDF] |
||||
![]() |
M. J. Lynch, E. L. Bove, T. N. Zweng, M. H. Fox, S. F. Boiling, and K. P. Gallagher Protection of the Neonatal Heart Following Normothermic Ischemia: A Comparison of Oxygenated Saline and Oxygenated versus Nonoxygenated Cardioplegia Ann. Thorac. Surg., June 1, 1988; 45(6): 650 - 655. [Abstract] [PDF] |
||||
![]() |
J. B. Rich, C. W. Akins, and W. M. Daggett Jr. Right Ventricular Failure Following Cardiopulmonary Bypass: Inadequate Myocardial Protection or Incomplete Revascularization? Ann. Thorac. Surg., June 1, 1988; 45(6): 693 - 694. [PDF] |
||||
![]() |
W. G. Hendren, D. D. O'Keefe, G. A. Geffin, A. G. Denenberg, T. R. Love, and W. M. Daggett Maximal Oxygenation of Dilute Blood Cardioplegic Solution Ann. Thorac. Surg., July 1, 1987; 44(1): 48 - 52. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |